SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: bob zagorin who wrote (27734)1/30/1999 9:55:00 PM
From: Arthur Radley  Read Replies (2) | Respond to of 32384
 
Bob,
I agree with you but would like to add...anyone investing in LGND shouldn't be doing it for Panretin and Ontak. Targretin is the drug that will make LGND and we should get information on the progress being made with Targretin in the not to distance future.
As for Panretin and Ontak, what other biotech will have TWO new drugs approved in such a short time frame and we all know, it will be the springboard for LGND into a profitable operation and not based on milestone payments from alliance partners. All just MO.



To: bob zagorin who wrote (27734)1/31/1999 4:01:00 PM
From: Skeeter Bug  Read Replies (1) | Respond to of 32384
 
bob, i see a gen'l market sell off and would like to lighten positions prior to it. i won't sell all my lgndw as you may be correct. we'll see. let's just hope we get approval soon... and not in june... like the fiasco w/ the leptin deal...


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News